Eupatilin treatment inhibits transforming growth factor beta-induced endometrial fibrosis in vitro.

MLA

Chang-Jin Lee, et al. “Eupatilin Treatment Inhibits Transforming Growth Factor Beta-Induced Endometrial Fibrosis in Vitro.” Clinical & Experimental Reproductive Medicine, vol. 47, no. 2, June 2020, pp. 108–13. EBSCOhost, https://doi.org/10.5653/cerm.2019.03475.

APA

Chang-Jin Lee, Seon-Hwa Hong, Min-Ji Yoon, Kyung-Ah Lee, Dong Hee Choi, Hwang Kwon, Jung-Jae Ko, Hwa Seon Koo, & Youn-Jung Kang. (2020). Eupatilin treatment inhibits transforming growth factor beta-induced endometrial fibrosis in vitro. Clinical & Experimental Reproductive Medicine, 47(2), 108–113. https://doi.org/10.5653/cerm.2019.03475

Chicago

Chang-Jin Lee, Seon-Hwa Hong, Min-Ji Yoon, Kyung-Ah Lee, Dong Hee Choi, Hwang Kwon, Jung-Jae Ko, Hwa Seon Koo, and Youn-Jung Kang. 2020. “Eupatilin Treatment Inhibits Transforming Growth Factor Beta-Induced Endometrial Fibrosis in Vitro.” Clinical & Experimental Reproductive Medicine 47 (2): 108–13. doi:10.5653/cerm.2019.03475.